Dr. Neetu Radhakrishnan, MD

  • Hamilton, OH
  • Hematologist and oncologist
NPI1508088147PAC ID2567561970
Medicare services, 2024
1,092
Medicare patients, 2024
206
Part D claims, 2024
1,070
Publications
1
Clinical trials
4
Practice address
630 Eaton Avenue, Hamilton, OH 45013
Practice phone
Call (513) 867-2123
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Kettering Health Hamilton

Hospital · Hamilton, Ohio

See all 6 affiliations

Find Dr. Radhakrishnan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Neetu Radhakrishnan is a hematologist and oncologist in Hamilton, Ohio

Dr. Radhakrishnan practices at Kettering Health Hamilton in Hamilton, Ohio, part of Kettering Adventist Healthcare.

Dr. Radhakrishnan's NPI, 1508088147, was assigned on May 3, 2007. Dr. Radhakrishnan holds Ohio license 35.094584.

NPI and contact details
Medicare PAC ID
2567561970
NPI enumeration date
May 3, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(513) 867-2123
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
55
Medical school graduation
1997

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Neetu Radhakrishnan practices at Kettering Health Hamilton in Hamilton, Ohio

Dr. Radhakrishnan's primary practice is Kettering Health Hamilton, at 630 Eaton Avenue, Hamilton, OH 45013 in Butler County. The practice phone is (513) 867-2123.

Source: Dmand AI Affiliation Data

Dr. Neetu Radhakrishnan is affiliated with 5 sites of care and 1 medical group

Dr. Radhakrishnan's primary practice is Kettering Health Hamilton in Hamilton, Ohio, part of Kettering Adventist Healthcare. Dr. Radhakrishnan is also affiliated with Kettering Health Dayton. The medical group on file is Kettering Health Medical Group. Dmand AI also links Dr. Radhakrishnan to 2 more hospitals and 1 group practice or clinic, each named with a free account.

See all 6 affiliations for Dr. Radhakrishnan

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Neetu Radhakrishnan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Radhakrishnan practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Kettering Health HamiltonAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Radhakrishnan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Kettering Adventist Healthcare and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Neetu Radhakrishnan is one of 460 hematologists and oncologists in Ohio

Hematology and oncology is Dr. Radhakrishnan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Radhakrishnan's licenses on file in 2 states: Ohio and New York.

Specialties and state licenses

  • Hematology and oncology, OhioPrimaryLicense 35.094584 · taxonomy 207RH0003X
  • New York licenseLicense 243492

Hematologists and oncologists near Dr. Radhakrishnan

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Neetu Radhakrishnan billed Medicare for 1,092 services in 2024

CMS data shows 1,092 Medicare services from Dr. Radhakrishnan across 7 procedure codes in 2024, for 206 Medicare patients. Medicare paid $76,303 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 20241,092
Medicare patients206
Paid by Medicare$76,303
Procedure codes7

Dr. Radhakrishnan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6702024: 74411%
Other services
2023: 02024: 348

Dr. Radhakrishnan compared with the Ohio median for hematologists and oncologists, 2024

  • Dr. Radhakrishnan
  • Ohio median
Medicare services
1,092vs 62674% above
Medicare patients
206vs 23412% below
Part D claims
775vs 47862% above

Medians across 452 hematologists and oncologists in Ohio with Dmand AI profiles that report each measure.

Dr. Radhakrishnan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Radhakrishnan

Need commercial claims for Dr. Radhakrishnan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Radhakrishnan and other hematologists and oncologists in Ohio.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Neetu Radhakrishnan treated 206 Medicare patients in 2024, average age 74

CMS counts 206 Medicare patients who saw Dr. Radhakrishnan in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Radhakrishnan's median patient age at 65, with 69% women.

Medicare patients, 2024206
Average age74
Average risk score2.36
Also on Medicaid17%

Dr. Radhakrishnan's Medicare patients by age, 2024

Dr. Radhakrishnan's Medicare patients by sex, 2024

  • Women13767%
  • Men6933%

Chronic conditions among Dr. Radhakrishnan's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis51%
  4. Ischemic heart disease46%
  5. Cancer42%
  6. Chronic kidney disease40%
  7. Depression39%
  8. Mood disorders39%

Share of Medicare patients with each condition. A patient can have several.

Dr. Radhakrishnan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 65

Patient panel by sex, all payers

  • Women69%
  • Men31%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Neetu Radhakrishnan wrote 1,070 Medicare Part D claims in 2024

In 2024, Dr. Radhakrishnan wrote 1,070 Medicare Part D claims for 197 patients. 84% of them were for generic drugs. CMS names the drug for 775 of them, across 30 drugs with 11 or more claims each, at $741,940 in total drug cost. In 2023, CMS named 745 claims across 29 drugs.

Part D claims, 20241,070
Drugs named by CMS30
Total drug cost$741,940
Part D patients197

Dr. Radhakrishnan's Part D claims by kind of drug, 2024

  • Generic895 claims84%
  • Brand-name175 claims16%

Dr. Radhakrishnan's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Radhakrishnan's Part D claims, 2024

  • Opioids6%62 of 1,070 claims
  • Antibiotics7%71 of 1,070 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7452024: 7754%

Drugs named by CMS: 30 in 2024, 29 in 2023.

See all prescribing by Dr. Radhakrishnan

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Neetu Radhakrishnan scored 81 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Radhakrishnan for performance year 2024, reported as part of a group. Dr. Radhakrishnan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Radhakrishnan's MIPS scores, performance year 2024

  • 81of 100Final score
  • 63.7of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 74of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Radhakrishnan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Neetu Radhakrishnan has 1 publication on record

Dmand AI links 1 paper to Dr. Radhakrishnan in 2014. Dr. Radhakrishnan's most frequent co-authors are Samer Alsidawi, MD and Abhimanyu Ghose, MD.

Papers1

Dr. Radhakrishnan's most frequent co-authors

Recent publications by Dr. Radhakrishnan

See all 1 publications and co-authors

See who Dr. Radhakrishnan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Radhakrishnan works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Neetu Radhakrishnan has worked on 4 clinical trials

Dmand AI links Dr. Radhakrishnan to 4 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Atypical Hemolytic Uremic Syndrome. Open Payments lists research payments to Dr. Radhakrishnan that name 1 trial.

Conditions in Dr. Radhakrishnan's trials

  • Breast Neoplasms
  • Breast Diseases
  • Atypical Hemolytic Uremic Syndrome
  • Triple Negative Breast Neoplasms
  • Hemolytic-Uremic Syndrome

Investigators on the most trials with Dr. Radhakrishnan

Recent clinical trials with Dr. Radhakrishnan

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Neetu Radhakrishnan received $1,927 in industry payments from 2017 to 2025

CMS Open Payments shows 18 general payments to Dr. Radhakrishnan from 15 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 60% of the total. Puma Biotechnology, Inc. paid the most, $1,017. It also lists 1 research payment totaling $3,000 in 2019, naming 1 clinical trial.

General payments to Dr. Radhakrishnan by program year, 2017 to 2025

General payments to Dr. Radhakrishnan by kind, 2017 to 2025

$1.9Kin total
  • Consulting fees$1,15060%
  • Food and beverage$49125%
  • Honoraria$1508%
  • Education$1367%

Companies that paid Dr. Radhakrishnan the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Radhakrishnan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Neetu Radhakrishnan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Neetu Radhakrishnan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Neetu Radhakrishnan's NPI number?

Dr. Neetu Radhakrishnan's NPI number is 1508088147. It was assigned on May 3, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Neetu Radhakrishnan?

Dr. Neetu Radhakrishnan is a hematologist and oncologist in Hamilton, Ohio. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Neetu Radhakrishnan practice?

Dr. Radhakrishnan practices at 630 Eaton Avenue, Hamilton, OH 45013. Dr. Radhakrishnan's primary practice is Kettering Health Hamilton in Hamilton, Ohio, part of Kettering Adventist Healthcare. Dmand AI also links Dr. Radhakrishnan to 2 hospitals and 1 group practice or clinic.

What is Dr. Neetu Radhakrishnan's office phone number?

The practice phone on file for Dr. Radhakrishnan is (513) 867-2123.

What is Dr. Neetu Radhakrishnan's medical license number?

Dr. Radhakrishnan holds Ohio license 35.094584, one of the licenses on file in 2 states.

Which states has Dr. Neetu Radhakrishnan been licensed in?

Dmand AI has state licenses on file for Dr. Radhakrishnan in Ohio and New York.

Which hospitals is Dr. Neetu Radhakrishnan affiliated with?

Dr. Radhakrishnan practices at Kettering Health Hamilton in Hamilton, Ohio. Dr. Radhakrishnan is also affiliated with Kettering Health Dayton. Dmand AI links Dr. Radhakrishnan to 2 more hospitals.

What medical group is Dr. Neetu Radhakrishnan part of?

Dr. Radhakrishnan is linked to Kettering Health Medical Group.

Does Dr. Neetu Radhakrishnan accept Medicare?

Yes. CMS data shows Dr. Radhakrishnan billed Medicare for 1,092 services in 2024, and Dr. Radhakrishnan accepts Medicare assignment.

What is Dr. Neetu Radhakrishnan's MIPS score?

Dr. Radhakrishnan's MIPS final score for performance year 2024 is 81 out of 100, reported as part of a group.

Show 7 more questionsShow fewer questions

How many Medicare patients does Dr. Neetu Radhakrishnan see?

CMS counts 206 Medicare patients who saw Dr. Radhakrishnan in 2024, with an average age of 74.

What services does Dr. Neetu Radhakrishnan bill to Medicare?

In 2024, Dr. Radhakrishnan's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).

What drugs does Dr. Neetu Radhakrishnan prescribe most?

In 2024 Medicare Part D data, Dr. Radhakrishnan's most prescribed drugs by claims were Letrozole, Anastrozole and Eliquis.

Has Dr. Neetu Radhakrishnan received payments from drug or device companies?

CMS Open Payments shows $1,927 in general payments to Dr. Radhakrishnan from 15 companies from 2017 to 2025. The largest total came from Puma Biotechnology, Inc.

How long has Dr. Neetu Radhakrishnan been practicing?

Dr. Radhakrishnan graduated from medical school in 1997, 29 years ago.

Does Dr. Neetu Radhakrishnan do research?

Dmand AI links 1 publication to Dr. Radhakrishnan. Dr. Radhakrishnan has worked on 4 clinical trials.

Who does Dr. Neetu Radhakrishnan publish with?

Dr. Radhakrishnan's most frequent co-authors are Samer Alsidawi, MD (1 shared paper) and Abhimanyu Ghose, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Ohio by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)